Citadel Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.99M Sell
640,000
-2,274,882
-78% -$21.3M ﹤0.01% 1759
2025
Q1
$35.8M Buy
2,914,882
+1,825,079
+167% +$22.4M 0.01% 614
2024
Q4
$14.4M Buy
1,089,803
+1,055,783
+3,103% +$14M ﹤0.01% 1113
2024
Q3
$655K Sell
34,020
-155,961
-82% -$3M ﹤0.01% 3512
2024
Q2
$3.9M Buy
189,981
+156,172
+462% +$3.21M ﹤0.01% 1877
2024
Q1
$805K Sell
33,809
-209,176
-86% -$4.98M ﹤0.01% 3420
2023
Q4
$5.25M Sell
242,985
-192,508
-44% -$4.16M ﹤0.01% 1617
2023
Q3
$6.32M Buy
435,493
+198,543
+84% +$2.88M ﹤0.01% 1452
2023
Q2
$4.96M Sell
236,950
-1,342,719
-85% -$28.1M ﹤0.01% 1731
2023
Q1
$33.4M Sell
1,579,669
-48,184
-3% -$1.02M 0.01% 609
2022
Q4
$41.4M Buy
1,627,853
+261,082
+19% +$6.64M 0.01% 522
2022
Q3
$32.8M Sell
1,366,771
-362,281
-21% -$8.71M 0.01% 564
2022
Q2
$33.3M Sell
1,729,052
-96,388
-5% -$1.85M 0.01% 575
2022
Q1
$31.7M Sell
1,825,440
-193,387
-10% -$3.36M 0.01% 640
2021
Q4
$44.2M Buy
2,018,827
+175,470
+10% +$3.84M 0.01% 533
2021
Q3
$35.2M Sell
1,843,357
-115,274
-6% -$2.2M 0.01% 603
2021
Q2
$33.6M Sell
1,958,631
-271,492
-12% -$4.66M 0.01% 676
2021
Q1
$49.9M Buy
2,230,123
+118,605
+6% +$2.65M 0.01% 472
2020
Q4
$47M Buy
2,111,518
+1,549,104
+275% +$34.5M 0.01% 452
2020
Q3
$8.3M Sell
562,414
-479,166
-46% -$7.07M ﹤0.01% 1209
2020
Q2
$15.4M Buy
1,041,580
+1,028,435
+7,824% +$15.2M 0.01% 866
2020
Q1
$144K Sell
13,145
-9,053
-41% -$99.2K ﹤0.01% 4217
2019
Q4
$195K Buy
+22,198
New +$195K ﹤0.01% 4148
2019
Q3
Hold
0
5096
2019
Q2
Hold
0
5063
2019
Q1
Sell
-35,007
Closed -$156K 4993
2018
Q4
$156K Sell
35,007
-23,048
-40% -$103K ﹤0.01% 3918
2018
Q3
$469K Buy
58,055
+35,557
+158% +$287K ﹤0.01% 3202
2018
Q2
$158K Buy
+22,498
New +$158K ﹤0.01% 3748